|
|
|||||||||
Basic Science Investigations |
Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa, Japan
| ABSTRACT |
|---|
|
|
|---|
74 mL, volume error was within ±15%, whereas for a small volume (34 mL), QGS and 4D-MSPECT underestimated the volume and pFAST overestimated it. The respective intra- and interobserver reproducibility of the results was good for QGS (r = 0.99 and 1.00), ECT (r = 0.98 and 0.98), and 4D-MSPECT (r = 0.98 and 0.98) and fair for pFAST (r = 0.88 and 0.85). The correlation coefficient for EF between gated SPECT and the GBP study was 0.82, 0.78, 0.69, and 0.84 for QGS, ECT, 4D-MSPECT, and pFAST, respectively. The correlation coefficient for EDV between gated SPECT and the GBP study was 0.88, 0.89, 0.85, and 0.90, respectively. Although good correlation was observed among the 4 software packages, QGS, ECT, and 4D-MSPECT overestimated EF in patients with small hearts, and pFAST overestimated the true volume in patients with large perfusion defects. Correlation coefficients among the 4 kinds of software were 0.800.95 for EF and 0.890.98 for EDV. Conclusion: All 4 software programs showed good correlation between EF or EDV and the GBP study. Good correlation was observed also between each pair of quantification methods. However, because each method has unique characteristics that depend on its specific algorithm and thus behaves differently in the various patient subgroups, the methods should not be used interchangeably.
Key Words: gated SPECT ventricular volume left ventricular ejection fraction software comparative study
| INTRODUCTION |
|---|
|
|
|---|
Several kinds of gated SPECT software for quantification have been developed and applied to clinical practice. These include Quantitative Gated SPECT (QGS, Cedars-Sinai Medical Center, Los Angeles, CA) (1,2), the Emory Cardiac Toolbox (ECT; Emory University, Atlanta, GA) (68), 4D-MSPECT (University of Michigan Medical Center, Ann Arbor, MI) (9,10), and Perfusion and Functional Analysis for Gated SPECT (pFAST; Sapporo Medical University, Sapporo, Japan) (11). All these programs have correlated well with conventional methods for calculating EF (25,813). However, only a few studies have compared several kinds of software using the same gated SPECT data. Thus, the purpose of this study was to validate the accuracy of EF and volume measurement in comparison with mathematic models and the standard GBP study and to evaluate correlations across the 4 software programs in computing gated SPECT parameters.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Patients
A total of 30 patients (20 males, 10 females; mean age ± SD, 49 ± 14 y) on whom both gated myocardial perfusion SPECT and a GBP study were performed within 2 wk of each other were analyzed retrospectively. The diagnoses for these patients consisted of old myocardial infarction (n = 8), angina pectoris (n = 9), subendocardial infarction (n = 1), cardiomyopathy (n = 3), diabetes mellitus (n = 1), hyperlipidemia (n = 1), systemic sclerosis (n = 2), and congenital cardiac disease (n = 5) including pulmonary stenosis, atrial septal defect, and ventricular septal defect. Six patients were analyzed after coronary artery bypass grafting, and 1 patient, after left ventricular aneurysmectomy. Three patients had associated congestive heart failure. Three pediatric patients were shown to be good candidates for gated perfusion SPECT for evaluation of ventricular function and myocardial damage. No patients had valvular regurgitation.
The patients were classified into 4 groups. Group 1 comprised 9 patients for whom resting perfusion SPECT found no perfusion defect. The average EF measured by the GBP study was 57% ± 8%. Group 2 comprised 10 patients with a small defect. The defects were in the inferior (n = 3), lateral (n = 3), septal (n = 2), inferolateral (n = 1), and apical (n = 1) walls. Group 3 comprised 6 patients with a large perfusion defect including the anterior wall, septum, and apex. Large defects were defined as more than one third of myocardial segments and were visually assessed by 2 nuclear medicine physicians, who reached a consensus. Mean ventricular volume and EF were 168 ± 52 mL and 27% ± 10% on the basis of the GBP study. Group 4 comprised 5 patients with small hearts. Small hearts were defined as those with an end-diastolic volume (EDV) < 60 mL as determined by the GBP study. Average ventricular volume was 40 ± 13 mL, and average ejection fraction was 55% ± 7%.
GBP Study
Radionuclide angiography and GBP scintigraphy were performed in the left anterior oblique projection with in vivo 99mTc labeling of red blood cells using a pyrophosphate kit (Daiichi Radioisotope Laboratory, Tokyo, Japan). Radionuclide angiography was performed by bolus injection of 99mTc-pertechnetate flushed with 20 mL saline. The data were acquired using a 64 x 64 matrix at 1 s per frame for 60 s. An equilibrium image was obtained 5 min later. The region of interest (ROI) was set over the left ventricle, and a timeactivity curve was generated. After exponential fitting using the descending portion of the curve based on a Stewardt-Hamilton equation, cardiac output was measured by the standard program supplied by the manufacturer (Toshiba Corp., Tokyo, Japan).
A GBP study was performed in the left anterior oblique best septal projection, right anterior oblique projection, and left lateral projection. EF was calculated using a variable ROI method, with a background ROI set along the left ventricular border on the end-diastolic image.
Stroke volume was calculated as cardiac output divided by heart rate, and EDV was calculated as stroke volume divided by EF (1). However, when EF is small, EDV may vary by a small change in EF. Thus, in the 3 patients whose EF was less than 30%, we used Simpsons rule to calculate EDV in either the left anterior oblique projection or the left lateral projection, in which the longer axis was shown. The long axis and ventricular ROI were carefully drawn by viewing a cine-mode display, and a 55%60% threshold was used to delineate the ventricular contour.
Gated Myocardial Perfusion SPECT
A dose of 7401,000 MBq 99mTc-methoxyisobutylisonitrile was injected while the patients were at rest. In children, a dose of 200400 MBq was used. Sixty 64 x 64 matrix projection images were obtained with a 6° step over 360° using a 3-detector SPECT system (9300A/HG; Toshiba).
Electrocardiographic gating was performed with 12 frames per cardiac cycle. In children, x1.5 or x2 zooming was used for data acquisition. After transaxial images were reconstructed with a ramp filter and with a Butterworth filter having a cutoff frequency of 0.43 cycles per centimeter (order 8), short-axis images were generated. Gated projection images were added before SPECT reconstruction to produce a nongated image and were used for visually evaluating the perfusion defect.
Gated SPECT Analysis
Four gated SPECT quantification methods were used for computing left ventricular EDVs and EFs. The algorithm of each kind of software has been described elsewhere (24,712). For computing the gated SPECT parameters, we used a UNIX system (GMS/UI; Toshiba) for QGS and ECT, e.soft (Toshiba/Siemens Medical Systems, Inc., Hoffman Estates, IL) on a Windows NT system (Microsoft, Redmond, WA) for 4D-MSPECT, and a Macintosh computer (Apple Computer, Inc., Cupertino, CA) with software that emulates Windows for a Macintosh user (Virtual PC 3.0; Connectix, San Mateo, CA) for pFAST.
We used version 2 of the QGS software (24). After a full set of short-axis images was selected, fully automatic sampling of 3-dimensional data was performed, providing final results. Fitted to a 3-dimensional ellipsoid, gaussian function was applied to determine myocardial borders.
The model for the ECT software (7,8) applies a 3-dimensional hybrid sampling technique that uses cylindric coordinates to sample from the basal wall to the distal wall and spheric coordinates to sample the apex. Because the program was designed to operate at only 8 frames per cardiac cycle, we extracted an initial 8 of 12 frames from the gated projection images. Although we excluded the last 4 frames, this processing did not alter the EDV and EF because the end-systolic frame was usually located at the fourth or fifth frame.
The 4D-MSPECT model (9,10) also uses a cylindricspheric coordinate system, with cylindric coordinates to sample from the basal wall to the distal wall and spheric coordinates to sample the apex. Weighted spline and thresholding techniques were used to refine surface estimates. Fitted to a gaussian function, wall position and thickness were estimated.
We used version 2 of the pFAST software (11), which is designed to operate on Windows for personal computers and transfers data online from a SPECT system. After the myocardium was automatically extracted, an ROI was set using spline interpolation. When the myocardial perfusion defect was large and fitting was judged inappropriate, the shape was adjusted manually. The radial profile curves were generated from the center. The distance from the myocardial maximum point to the epicardial border was defined as 50% of the maximum count. The endocardial border was calculated as the distance from the center to the myocardial peak count plus k times wall thickness, where k is empirically determined to be 0.35.
Automatic processing was initially used for all software. When the wall tracing was visually judged inappropriate, the operator modified the ventricular border surrounding the ventricle and reprocessed the edge.
Intraobserver and interobserver reproducibility was examined in the first 20 patients. Intraobserver variability was tested 1 mo later by the same operator. Two nuclear medicine physicians independently processed each dataset, beginning with the projection images and continuing through reconstruction and gated SPECT analysis.
Statistics
Values were expressed as mean ± SD. The difference among the EF results was shown in absolute EF units (as a percentage), not by percentage of EFs. Linear regression analysis was performed by least squares fitting. The average values of 2 operators were used for calculating the regression line. The correlation coefficients of gated SPECT parameters among the 4 methods and GBP studies were calculated, as was the SE of the regression slope. The differences between the 2 selected groups were examined by repeated-measures ANOVA with Fisher protected least significant difference (PLSD) and Scheffé tests (StatView, version 5.0J; SAS Institute, Inc., Cary, NC). These multiple comparisons were performed for all possible combinations. The differences in EF or EDV were plotted against the mean values according to the BlandAltman method (17). P < 0.05 was considered statistically significant.
| RESULTS |
|---|
|
|
|---|
74 mL. QGS determined the correct volume in chambers
150 mL. However, QGS underestimated the volume in small chambers. ECT slightly overestimated the theoretic volume by about 10%. No underestimation was seen even in the 34-mL chamber. 4D-MSPECT showed <10% error when the volume was
74 mL but underestimated the 34-mL volume. On the other hand, pFAST overestimated the 34-mL volume.
|
Clinical Studies
Good correlations were found between the 4 gated SPECT methods and the standard GBP method for the EF and EDV calculations (Fig. 1). For EF, linear regression lines between gated SPECT (Y) and the GBP study (X) were calculated as Y = 1.06X + 2.3 (r = 0.82; P < 0.0001; SE = 0.14) for QGS, Y = 1.12X + 3.70 (r = 0.78; P < 0.0001; SE = 0.17) for ECT, Y = 0.99X + 6.6 (r = 0.69; P < 0.0001; SE = 0.20) for 4D-MSPECT, and Y = 1.14X - 4.80 (r = 0.84; P < 0.0001; SE = 1.14) for pFAST. All regression lines were near one another. For EDV, linear regression lines between gated SPECT and the GBP study were calculated as Y = 1.04X - 8.5 (r = 0.88; P < 0.0001; SE = 0.11) for QGS, Y = 1.18X - 14.9 (r = 0.89; P < 0.0001; SE = 0.11) for ECT, Y = 1.00X + 0.39 (r = 0.85; P < 0.0001; SE = 0.12) for 4D-MSPECT, and Y = 1.61X - 35.9 (r = 0.90; P < 0.0001; SE = 0.15) for pFAST. The slope of the regression line calculated from pFAST showed the highest value.
|
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Based on the mathematic models, the calculated error of EDV was within 15% of the actual EDV when the volume was
74 mL. However, a smaller, 37-mL, volume was significantly underestimated by QGS and 4D-MSPECT and overestimated by pFAST. Underestimation of left ventricular volume with QGS has been described previously (14,15), and our findings agree with those previous findings. In a study using a simulation phantom, Achtert et al. (14) found that QGS slightly overestimated EF and underestimated EDV. 4D-MSPECT also underestimated EDV. On the other hand, because the results of pFAST varied by zooming factors during processing, we selected the best ventricular tracing by repeated trials. The pFAST algorithm overestimated the small volume, and this overestimation may be attributed to the modified thresholding method used to detect the edge (11). In addition, the shape of the mathematic model of our study was a cylindrichemispheric hybrid and was similar to the ECT and 4D-MSPECT models. This assumption may result in better fitting by the ECT and 4D-MSPECT models. Nichols et al. (13), in discussing clinical studies, also noted the similarity of the assumption in the model.
QGS showed the best reproducibility and was not significantly influenced by variations in the setting of the cardiac long axis during SPECT. The cases requiring manual constraint involved patients with large anteroseptal or apical perfusion defects. Edge detection methods worked well in patients with moderate or small perfusion defects. QGS, because correlating well with the GBP study and other gated SPECT software, is considered to be a convenient tool for quantification (25), although a canine MRI study showed the QGS method to have limitations (16). Underestimation of volume was observed in the current study and had also been reported previously (14,15). Our previous simulation study (15) indicated that underestimation was 75% for a 50-mL volume and 50% for a 37-mL volume. Zooming and depth-dependent filtering to overcome the underestimation in small hearts have been proposed (18). Because our previous study (15) showed that hardware zooming during data acquisition was the simplest way to improve accuracy, we used zooming in small patients. Still, the underestimation could not be avoided. Although underestimation of left ventricular EF in the presence of a large defect has been reported (19), our limited number of groups did not show a tendency toward such an underestimation.
ECT was also good in terms of reproducibility and correlated well with the GBP study. The good correlation with theoretic values in the mathematic model may stem from the similarity in the assumption, as described above (68). In clinical studies on patients without a perfusion defect, EF was slightly higher as calculated by ECT than in the GBP study and was overestimated in small hearts, as occurred with QGS. Although a tracing of the ventricular contour was not displayed in the long-axis images, fitting was good in the short-axis images.
The EFs calculated by 4D-MSPECT correlated well with those calculated by the other 3 methods. Although slightly higher than found by the GBP study, EF did not differ significantly in each group for 4D-MSPECT compared with QGS. The fair correlation with the GBP study (r = 0.68) may be explained by the determination of the basal border. In some patients, the basal border did not agree with visual assessment because it was determined by the single plane perpendicular to the long axis of the heart. In addition, because an apical border was detected slightly outside the apical wall in the small mathematic phantom, the problem of a small heart was again significant when this software was used.
pFAST correlated best with the GBP study. This algorithm used a modified thresholding method, which was essentially different from the other 3 methods. The volume can be modified by the setting of a k value (11), and because this k value was adjusted to give a good correlation with the GBP study, the good correlation may be a result of this method. The tendency to obtain a higher EDV by pFAST may also contribute to a relatively higher correlation. The algorithm failed to detect large defects and, in comparison with the GBP study and the 3 other methods, overestimated the volume. Because a minor modification was required for constrained tracing even when defects were moderate, this software required careful setting. The algorithm for completely automatic processing without manual modification should be improved to increase reproducibility. Among the 4 methods, pFAST overestimated EF the least.
This study had some limitations. Because the GBP study has been used as a standard and reproducible method for evaluating ventricular contraction, we selected the GBP result as a "true" value. For calculating EDV, we used a combination of output measurements derived from radionuclide angiography and EF from the GBP study. However, because EDV was calculated as cardiac output divided by heart rate (i.e., stroke volume) divided by EF, EDV may be affected by slight changes in EF when EF is small. Thus, in this study we used Simpsons rule in a planar view that best showed the long axis of the heart. Although a count-based method may be used for computing volume, attenuation correction and blood sampling may be required (20,21), and we did not perform these routinely. Moreover, true volume in patient studies could not be completely defined, because all conventional methods have specific assumptions and because calculated values may also reflect patient characteristics such as chamber size and extent of perfusion defects. Determination of reference values for gated SPECT technology is important in this respect (22). Another limitation is the small number of patients. Although further classification into the 4 groups left too few patients in each group for reliability, the purpose of classification into small groups was to evaluate the factors for variability in various settings. Because our patient population was heterogeneous with respect to ventricular size and extent of defect, we believed that the classification into groups would be better than the use of the BlandAltman plot as a single group. Finally, because all 4 software programs are still in revision, the purpose of this study was not to determine the best software package but to understand the characteristics and common features of the currently available software.
| CONCLUSION |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
For correspondence or reprints contact: Kenichi Nakajima, MD, Department of Nuclear Medicine, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, 920-8641, Japan.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
W. M. Schaefer, C. S.A. Lipke, D. Standke, H. P. Kuhl, B. Nowak, H.-J. Kaiser, K.-C. Koch, and U. Buell Quantification of Left Ventricular Volumes and Ejection Fraction from Gated 99mTc-MIBI SPECT: MRI Validation and Comparison of the Emory Cardiac Tool Box with QGS and 4D-MSPECT J. Nucl. Med., August 1, 2005; 46(8): 1256 - 1263. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fricke, H. Fricke, R. Weise, A. Kammeier, R. Hagedorn, N. Lotz, O. Lindner, D. Tschoepe, and W. Burchert Attenuation Correction of Myocardial SPECT Perfusion Images with Low-Dose CT: Evaluation of the Method by Comparison with Perfusion PET J. Nucl. Med., May 1, 2005; 46(5): 736 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Manrique, A. Hitzel, D. Brasse, and P. Vera Effect of Perfusion Pattern and Imaging Sequence on Gated Perfusion SPECT Evaluation of Myocardial Stunning J. Nucl. Med., January 1, 2005; 46(1): 176 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Paul and H. A. Nabi Gated Myocardial Perfusion SPECT: Basic Principles, Technical Aspects, and Clinical Applications J. Nucl. Med. Technol., December 1, 2004; 32(4): 179 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Go, M. R. Bhatt, and R. C. Hendel The Diagnostic and Prognostic Value of ECG-Gated SPECT Myocardial Perfusion Imaging J. Nucl. Med., May 1, 2004; 45(5): 912 - 921. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Schaefer, C. S.A. Lipke, B. Nowak, H.-J. Kaiser, P. Reinartz, A. Buecker, G. A. Krombach, U. Buell, and H. P. Kuhl Validation of QGS and 4D-MSPECT for Quantification of Left Ventricular Volumes and Ejection Fraction from Gated 18F-FDG PET: Comparison with Cardiac MRI J. Nucl. Med., January 1, 2004; 45(1): 74 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Okazawa, M. Takahashi, T. Hata, K. Sugimoto, Y. Kishibe, and T. Tsuji Quantitative Evaluation of Myocardial Blood Flow and Ejection Fraction with a Single Dose of 13NH3 and Gated PET J. Nucl. Med., August 1, 2002; 43(8): 999 - 1005. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |